Paul Tudor Jones’s Sanofi SNY Stock Holding History

Paul Tudor Jones’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-8,259	Closed	-$332K	–	1896
2016 Q1	$332K	Buy	8,259 +2,450	+42%	+$98.4K	0.01%	1230
2015 Q4	$248K	Hold	5,809	–	–	0.01%	1328
2015 Q3	$276K	Buy	+5,809	New	+$296K	0.01%	1153
2015 Q2	–	Sell	-7,598	Closed	-$376K	–	1665
2015 Q1	$376K	Buy	+7,598	New	+$363K	0.01%	912

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Paul Tudor Jones's SNY Position: Q2 2016 in Review

Paul Tudor Jones sold out of Sanofi (SNY) in Q2 2016, closing a stake of 8,259 shares — an estimated $332K sold.

Paul Tudor Jones first reported a position in SNY in Q1 2015 and held it in 4 quarters. The position peaked at $376K in Q1 2015. 450 funds tracked by Wall St. Rank hold SNY as of Q2 2016.

Paul Tudor Jones reported no remaining Sanofi position as of Q2 2016 after selling out during the quarter.
Paul Tudor Jones sold 8,259 Sanofi shares in Q2 2016, an estimated $332K.
Paul Tudor Jones first reported a position in Sanofi in Q1 2015 and held it in 4 quarters.
Paul Tudor Jones's Sanofi position peaked at $376K in Q1 2015.
450 funds tracked by Wall St. Rank held Sanofi as of Q2 2016.

Based on Tudor Investment Corp's 13F filing for Q2 2016, filed 15 Aug 2016.